10 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Article Searches
What's in Store for Boston Scientific (BSX) in Q4 Earnings? https://www.zacks.com/stock/news/2211533/what-s-in-store-for-boston-scientific-bsx-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2211533 Jan 17, 2024 - Boston Scientific (BSX) is expected to have witnessed strong growth of the WATCHMAN franchise in the fourth quarter, given the FDA approval of WATCHMAN FLX Pro in September.
Can Masimo (MASI) Run Higher on Rising Earnings Estimates? https://www.zacks.com/stock/news/2213660/can-masimo-masi-run-higher-on-rising-earnings-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2213660 Jan 22, 2024 - Masimo (MASI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Intuitive Surgical (ISRG) Seeks FDA Nod for Next-Gen da Vinci 5 https://www.zacks.com/stock/news/2216520/intuitive-surgical-isrg-seeks-fda-nod-for-next-gen-da-vinci-5?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2216520 Jan 26, 2024 - Intuitive Surgical (ISRG) aims to boost its da Vinci portfolio with the addition of its next-generation da Vinci 5 multiport surgical robot.
Company News for Mar 26, 2024 https://www.zacks.com/stock/news/2245969/company-news-for-mar-26-2024?cid=CS-ZC-FT-corporate_summary-2245969 Mar 26, 2024 - Companies in The News:MASI,CLFAMD,UAL
Apple's Win https://www.fool.com/investing/2024/01/10/apples-win/?source=iedfolrf0000001 Jan 10, 2024 - We've also got some productivity tips for the new year.
Here's Why You Should Retain Masimo (MASI) Stock for Now https://www.zacks.com/stock/news/2210710/here-s-why-you-should-retain-masimo-masi-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2210710 Jan 16, 2024 - Masimo's (MASI) R&D activities raise optimism about the stock.
What's in Store for Edwards Lifesciences (EW) in Q4 Earnings? https://www.zacks.com/stock/news/2212913/what-s-in-store-for-edwards-lifesciences-ew-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2212913 Jan 19, 2024 - Edwards Lifesciences' (EW) Q4 results are likely to reflect continued demand for its state-of-the-art HemoSphere monitoring platform and Smart Recovery portfolio in Critical Care.
Here's Why You Should Add Masimo (MASI) to Your Portfolio Now https://www.zacks.com/stock/news/2227728/here-s-why-you-should-add-masimo-masi-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2227728 Feb 19, 2024 - Masimo's (MASI) R&D activities raise optimism about the stock.
Are Medical Stocks Lagging Masimo (MASI) This Year? https://www.zacks.com/stock/news/2230943/are-medical-stocks-lagging-masimo-masi-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2230943 Feb 23, 2024 - Here is how Masimo (MASI) and CochLear Ltd. Unsponsored ADR (CHEOY) have performed compared to their sector so far this year.
Masimo (MASI) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates https://www.zacks.com/stock/news/2232801/masimo-masi-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2232801 Feb 27, 2024 - The headline numbers for Masimo (MASI) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Pages: 1

Page 1